News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
SUBSCRIBE
Menu
SUBSCRIBE
Show Search
News
Drug Development
FDA
Drug Delivery
Deals
Business
Policy
Cell and Gene Therapy
Weight Loss
Rare Disease
Cancer
Job Trends
Artificial Intelligence
NextGen: Top Start Ups to Watch
Podcasts
Reports
Webinars
Press Releases
All News & Releases
Insights
Jobs
Career Advice
Companies
Hotbeds
More
Best Places to Work
Employer Resources
Post Jobs
Talent Solutions
Advertise
Submit a Press Release
Search Query
Submit Search
Search Results
Submit
Looking for jobs?
Search jobs
Close
197,559 Results
Type
Article (19387)
Company Profile (104)
Press Release (178068)
Section
Business (63614)
Career Advice (819)
Deals (8985)
Drug Delivery (72)
Drug Development (18620)
Employer Resources (138)
FDA (3299)
Job Trends (5971)
News (94744)
Policy (7008)
Tag
2024 BioForest Digital (2)
2024 BioForest Standard (1)
2024 BioMidwest Digital (3)
2024 BioMidwest Standard (2)
2024 Bio NC Digital (6)
2024 Bio NC Standard (1)
2024 Biotech Bay Standard (9)
2024 Biotech Beach Digital (3)
2024 Biotech Beach Standard (6)
2024 Genetown Standard (4)
2024 Lone Star Bio Digital (1)
2024 Pharm Country Digital (2)
2024 Pharm Country Standard (5)
2025 Lone Star Bio Digital (2)
2026 BioCapital Elite (1)
2026 BioMidwest Elite (1)
2026 Biotech Beach Elite (1)
2026 Genetown Elite (1)
2026 Pharm Country Standard (1)
Academia (1491)
Academic (2)
Accelerated approval (1)
Adcomms (16)
Allergies (18)
Alliances (17275)
ALS (25)
Alzheimer's disease (526)
Antibody-drug conjugate (ADC) (54)
Approvals (3296)
Artificial intelligence (117)
Autoimmune disease (4)
Automation (7)
Bankruptcy (50)
Best Places to Work (4886)
BIOSECURE Act (11)
Biosimilars (45)
Biotechnology (64)
Bladder cancer (22)
Brain cancer (6)
Breast cancer (82)
Cancer (542)
Cardiovascular disease (52)
Career advice (720)
Career pathing (29)
CAR-T (50)
Cell therapy (136)
Cervical cancer (5)
Clinical research (14092)
Collaboration (334)
Compensation (67)
Complete response letters (7)
COVID-19 (953)
CRISPR (16)
C-suite (100)
Cystic fibrosis (38)
Data (535)
Decentralized trials (1)
Denatured (21)
Depression (15)
Diabetes (62)
Diagnostics (2408)
Digital health (5)
Diversity (7)
Diversity, equity & inclusion (37)
Drug discovery (48)
Drug pricing (43)
Drug shortages (4)
Duchenne muscular dystrophy (30)
Earnings (14475)
Editorial (10)
Employer branding (23)
Employer resources (118)
Events (29384)
Executive appointments (329)
FDA (3566)
Featured Employer (33)
Friedreich's ataxia (1)
Frontotemporal dementia (3)
Funding (301)
Gene editing (34)
Generative AI (14)
Gene therapy (93)
GLP-1 (292)
Government (1305)
Guidances (17)
Healthcare (4921)
Huntington's disease (13)
IgA nephropathy (8)
Immunology and inflammation (21)
Indications (4)
Infectious disease (1003)
Inflammatory bowel disease (55)
Inflation Reduction Act (7)
Influenza (12)
Intellectual property (26)
Interviews (115)
IPO (3624)
IRA (16)
Job creations (1299)
Job search strategy (633)
Kidney cancer (1)
Labor market (26)
Layoffs (153)
Leadership (9)
Legal (1171)
Liver cancer (21)
Lung cancer (85)
Lymphoma (47)
Machine learning (1)
Management (42)
Manufacturing (111)
MASH (10)
Medical device (2594)
Medtech (2598)
Mergers & acquisitions (5561)
Metabolic disorders (193)
Multiple sclerosis (31)
NASH (9)
Neurodegenerative disease (22)
Neuropsychiatric disorders (4)
Neuroscience (688)
NextGen: Class of 2025 (2080)
Non-profit (1670)
Northern California (691)
Now hiring (35)
Obesity (123)
Opinion (92)
Ovarian cancer (20)
Pain (27)
Pancreatic cancer (12)
Parkinson's disease (39)
Partnered (10)
Patents (42)
Patient recruitment (18)
Peanut (13)
People (26885)
Pharmaceutical (25)
Pharmacy benefit managers (1)
Phase I (4169)
Phase II (5834)
Phase III (5592)
Pipeline (218)
Podcasts (28)
Policy (44)
Postmarket research (558)
Preclinical (2364)
Press Release (61)
Prostate cancer (22)
Psychedelics (18)
Radiopharmaceuticals (62)
Rare diseases (106)
Real estate (2512)
Recruiting (54)
Regulatory (5033)
Reports (33)
Research institute (1257)
Resumes & cover letters (106)
RNA editing (1)
RSV (22)
Schizophrenia (21)
Series A (62)
Series B (35)
Service/supplier (8)
Sickle cell disease (21)
Southern California (486)
Special edition (8)
Sponsored (13)
Startups (1990)
State (1)
Stomach cancer (6)
Supply chain (19)
The Weekly (7)
United States (5996)
Vaccines (187)
Venture capitalists (25)
Webinars (9)
Weight loss (88)
Women's health (12)
Worklife (14)
Date
Today (50)
Last 7 days (189)
Last 30 days (876)
Last 365 days (10842)
2025 (2040)
2024 (11399)
2023 (12958)
2022 (15564)
2021 (17683)
2020 (16292)
2019 (14967)
2018 (10808)
2017 (10306)
2016 (10169)
2015 (10875)
2014 (8005)
2013 (6919)
2012 (7358)
2011 (7537)
2010 (7024)
Location
Africa (324)
Alabama (21)
Alaska (4)
Arizona (60)
Arkansas (4)
Asia (11161)
Australia (1954)
California (1470)
Canada (556)
China (118)
Colorado (84)
Connecticut (60)
Delaware (67)
Europe (28875)
Florida (225)
Georgia (50)
Hawaii (1)
Idaho (11)
Illinois (119)
India (14)
Indiana (132)
Iowa (4)
Japan (58)
Kansas (27)
Kentucky (7)
Louisiana (3)
Maine (6)
Maryland (180)
Massachusetts (1237)
Michigan (86)
Minnesota (105)
Mississippi (1)
Missouri (27)
Montana (4)
Nebraska (9)
Nevada (10)
New Hampshire (12)
New Jersey (495)
New Mexico (15)
New York (573)
North Carolina (300)
North Dakota (7)
Northern California (691)
Ohio (61)
Oklahoma (5)
Oregon (15)
Pennsylvania (242)
Puerto Rico (2)
Rhode Island (7)
South America (390)
South Carolina (5)
Southern California (486)
Tennessee (28)
Texas (194)
Utah (38)
Virginia (38)
Washington D.C. (22)
Washington State (127)
Wisconsin (26)
197,559 Results for "quotient sciences".
Filters
Sort By
Relevance
Relevance
Newest
Oldest
Collaboration
Pfizer Partners With Flagship’s Quotient to Leverage Genetics Against Heart, Renal Diseases
Quotient Therapeutics’ platform targets somatic mutations, which the startup contends can help identify a broader scope of genes potentially associated with disease phenotypes. Wednesday’s agreement is part of an existing partnership between Pfizer and Flagship Pioneering.
August 28, 2024
·
2 min read
·
Tristan Manalac
Press Releases
Quotient Therapeutics Appoints Sir Mene Pangalos, Ph.D. to Board of Directors
November 8, 2024
·
3 min read
Press Releases
Quotient Therapeutics Appoints Peter Campbell, Ph.D. as Chief Scientific Officer
August 7, 2024
·
2 min read
Press Releases
Flagship Pioneering and Quotient Therapeutics Announce Agreement to Identify Potential Novel Targets for the Treatment of Cardiovascular and Renal Diseases under Strategic Partnership with Pfizer
August 28, 2024
·
4 min read
Business
Money Meets Medicine: A Disruptor’s Guide to Life Sciences Investment
In this episode of Denatured, BioSpace’s Head of Insights Lori Ellis and Miruna Sasu, CEO of COTA, discuss life sciences investment and the potential for disruption.
February 27, 2025
·
1 min read
·
Lori Ellis
Venture capitalists
Blackstone Launches New $5B+ Fund for Life Sciences
Blackstone joins other big investors such as ARCH Venture Partners and Bain Capital Life Sciences in pumping billions of dollars into the industry.
January 31, 2025
·
2 min read
·
Tristan Manalac
Biotech Beach
Ensysce Biosciences Continues Collaboration to Advance the Clinical Development of Innovative Overdose Protection Platform
Ensysce Biosciences, Inc. today announced the renewal of its collaboration with Quotient Sciences to undertake the study PF614-MPAR-102 to examine and evaluate the full commercial dose range of the PF614-MPAR drug product.
May 20, 2024
·
5 min read
Drug Development
Healthcare at a Crossroads: Maintaining Good Science in Uncertain Times
Continuing our SCOPE 2025 coverage, Rohit Nambisan, CEO at Lokavant addresses not only current challenges, but the life sciences industry’s responsibility to maintain scientific integrity.
February 17, 2025
·
1 min read
·
Lori Ellis
Business
Nanomerics Announces Quotient Sciences as its Clinical Trials Partner
Nanomerics Ltd., a private speciality pharmaceutical company, announced that the Company had signed an agreement with Quotient Sciences, a drug development and manufacturing accelerator, for the delivery of its Sunlight Trial.
March 28, 2022
·
4 min read
Business
Philadelphia’s Life Sciences Scene Making Its Mark
The Philadelphia market has gained recognition not only for its cell and gene therapy sector but also its real estate scene and talent pool. Vittoria Biotherapeutics, Interius BioTherapeutics and Chamber of Commerce for Greater Philadelphia executives share why the area is a life sciences hot spot.
February 20, 2025
·
7 min read
·
Angela Gabriel
1 of 19,756
Next
